SCHEMBL7347580

SCHEMBL7347580

CC1CCN(C(=O)CNC(=O)OC(C)(C)C)[C@H](C(=O)O)C1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
SIGMAR1 Q99720 1/20 0.39
BTK Q06187 1/20 0.39
ACE P12821 1/20 0.39
HDAC8 Q9BY41 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.36
EPHX1 P07099 1/20 0.35
MMP1 P03956 1/20 0.35
MMP9 P14780 1/20 0.35
MMP13 P45452 1/20 0.35
DRD2 P14416 1/20 0.34
FAP Q12884 2/20 0.34
PREP P48147 1/20 0.34
KLK5 Q9Y337 1/20 0.34
GAA P10253 1/20 0.33
CACNA1H O95180 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7347574 1.00 KMT2A (0.46) KMT2AMEN1ALDH1A1TSHRSIGMAR1
SCHEMBL8703103 1.00 KMT2A (0.46) KMT2AMEN1ALDH1A1TSHRSIGMAR1
SCHEMBL1925210 0.83 ACE (0.53) KMT2AMEN1ALDH1A1TSHRBTK
SCHEMBL1000948 0.83 ACE (0.53) KMT2AMEN1ALDH1A1TSHRBTK
SCHEMBL23462265 0.82 ATM (0.48) KMT2AMEN1ALDH1A1TSHRSIGMAR1
Hydrochloric Acid SCHEMBL10976646 0.82 ACE (0.52) KMT2AMEN1ALDH1A1TSHRBTK
SCHEMBL29843876 0.80 ACE (0.42) KMT2AMEN1ALDH1A1TSHRBTK
SCHEMBL1633743 0.80 KMT2A (0.53) KMT2AMEN1ALDH1A1TSHRSIGMAR1
SCHEMBL7264251 0.79 ACE (0.49) KMT2AMEN1ALDH1A1TSHRACE
SCHEMBL58503 0.78 HSD17B10 (0.50) BTKSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5583146-A Heterocyclic thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1996-12-10 US disclosed
EP-0601459-A2 Sulfonamido heterocyclic thrombin inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1994-06-15 EP disclosed